SLC11A1 rs1800547: What Your Genotype Means
The rs1800547 variant is a genetic change located within the SLC11A1 gene, which encodes a protein critical for immune cell function. Research has investigated this variant for its potential role in influencing human susceptibility to infectious diseases like tuberculosis and leprosy.
What each genotype means
Typical SLC11A1 profile
This genotype represents the most common genetic configuration for this position in many populations. Research into SLC11A1 suggests this gene plays a role in macrophage activation and immune response, though the specific impact of this variant remains a subject of ongoing study with limited evidence for clinical application.
This is the most frequent genotype observed in most global populations, though frequencies vary significantly by ancestry.
Variant carrier status
Carrying one copy of the minor allele may influence how your immune system regulates macrophage activity, which is involved in the body's response to certain pathogens. Current evidence is limited and mixed regarding whether this specific genotype confers a meaningful difference in susceptibility to infectious or autoimmune conditions.
This heterozygous genotype is found in approximately 15-30% of individuals depending on their ancestral background.
Minor allele homozygous profile
This genotype results in two copies of the minor allele, which has been investigated for its potential role in altering SLC11A1 protein function. While some studies explore associations with immune-related traits, the evidence remains limited and inconsistent across different ethnic cohorts.
This genotype is less common, appearing in a smaller percentage of the population, with higher prevalence noted in certain African cohorts compared to European populations.
Understanding the SLC11A1 Gene
The SLC11A1 gene, formerly known as NRAMP1 (Natural Resistance-Associated Macrophage Protein 1), plays a vital role in the human innate immune system. It encodes a protein that functions as a metal transporter, specifically moving iron and other cations across the membranes of phagosomes within macrophages. Macrophages are specialized immune cells that engulf and destroy invading pathogens. By regulating the concentration of metals within these compartments, the SLC11A1 protein helps control the environment where microbes reside after being ingested by the cell. This process is essential for the effective activation of macrophages and the subsequent host response to intracellular pathogens. Because of its central role in immune defense, researchers have long studied variations in this gene to understand why some individuals may be more susceptible to certain infections than others.
The rs1800547 Variant
The rs1800547 variant is a specific polymorphism found within the SLC11A1 gene. In the context of genetic research, a polymorphism is a common variation in the DNA sequence among individuals. This particular variant has been the subject of numerous studies investigating its functional impact on the immune system. Some research suggests that variations in SLC11A1 may influence the production of cytokines, such as interleukin-10, which are signaling molecules that help regulate the intensity of the immune response. By altering how macrophages respond to infection, this variant is hypothesized to potentially shift the balance between an effective immune defense and increased susceptibility to disease. However, it is important to note that the functional consequences of this specific SNP are complex and may depend on the presence of other genetic or environmental factors.
Research and Evidence Strength
The association between SLC11A1 variants and infectious diseases like tuberculosis and leprosy has been a significant area of study for decades. While early research identified potential links between specific SLC11A1 polymorphisms and disease risk, the evidence remains limited and sometimes inconsistent across different populations. Some studies have reported that certain genotypes are associated with an increased risk of tuberculosis, while others have found no significant difference in disease susceptibility. These mixed results highlight the complexity of genetic associations, which are often influenced by the genetic background of the population being studied and environmental exposures. Currently, the evidence for rs1800547 as a definitive predictor of disease risk is considered limited. It is not a diagnostic tool, and its presence does not guarantee that an individual will develop any specific condition.
Population Frequency
The frequency of the rs1800547 variant varies significantly across different global populations. Data indicates that the minor allele frequency is approximately 0.08 in European cohorts, while it is notably higher, around 0.20, in African cohorts. These differences in allele frequency are common in human genetics and reflect the diverse evolutionary histories of different populations. Understanding these variations is crucial for researchers when interpreting the results of genetic association studies, as a variant that is common in one group may be rare in another, potentially affecting the statistical power and reproducibility of research findings.
Interpreting Your Genetic Information
If you have information about your genotype for rs1800547, it is important to view it within the context of current scientific understanding. This variant is a subject of ongoing research and is not used in clinical practice to diagnose or predict the risk of tuberculosis or other infections. Genetic factors are only one piece of a much larger puzzle that includes environmental exposures, lifestyle, and overall health. You cannot use this information to make medical decisions or to determine your personal risk for specific diseases. If you have concerns about your health, your immune system, or your risk for infectious diseases, the most appropriate step is to consult with a qualified healthcare professional. They can provide guidance based on your complete medical history and current clinical guidelines, rather than relying on individual genetic markers.
How common is this variant?
The minor allele frequency for rs1800547 is approximately 0.08 in European populations and approximately 0.20 in African cohorts.
Frequently asked questions
Does having the rs1800547 variant mean I will get tuberculosis?
No. The presence of this variant does not mean you will develop tuberculosis. Tuberculosis is an infectious disease caused by bacteria, and genetic variants like rs1800547 are only one of many factors that may influence how your immune system responds to exposure.
Is rs1800547 a diagnostic test for immune health?
No, rs1800547 is not a diagnostic test. It is a genetic polymorphism studied in research settings to understand immune function, and it is not used by doctors to assess your overall immune health or to diagnose any medical condition.
Why do studies show different results for this variant?
Genetic association studies often show different results because of differences in the populations studied, sample sizes, and environmental factors. Because infectious disease risk is complex, a single genetic variant rarely has the same effect across all people and environments.
Should I be worried about my genotype for this SNP?
There is no reason to be worried about your genotype for this SNP. It is a common variation found in many healthy individuals, and current evidence does not support using this information to change your daily life or medical care.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800547?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29